Literature DB >> 8102511

Vitamin E treatment of tardive dyskinesia.

L A Adler1, E Peselow, J Rotrosen, E Duncan, M Lee, M Rosenthal, B Angrist.   

Abstract

OBJECTIVE: The authors studied the effects of vitamin E treatment of tardive dyskinesia; earlier studies have produced contradictory results.
METHOD: Twenty-eight patients with tardive dyskinesia were treated in a double-blind, parallel-group comparison study of 8-12 weeks of treatment with vitamin E (1600 IU/day) or matching placebo capsules.
RESULTS: The Abnormal Involuntary Movement Scale scores of the patients treated with vitamin E improved significantly compared to the scores of the patients given placebo.
CONCLUSIONS: These results support earlier findings of the efficacy of vitamin E in treating tardive dyskinesia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102511     DOI: 10.1176/ajp.150.9.1405

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  25 in total

Review 1.  Oxidative mechanisms and tardive dyskinesia.

Authors:  James B Lohr; Ronald Kuczenski; Alexander B Niculescu
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Tardive Dyskinesia.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

Review 3.  Melatonin, sleep, aging, and the health protection branch.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

Review 4.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

5.  No association between a functional NAD(P)H: quinone oxidoreductase gene polymorphism (Pro187Ser) and tardive dyskinesia.

Authors:  Hiroko Hori; Takahiro Shinkai; Chima Matsumoto; Osamu Ohmori; Jun Nakamura
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 6.  Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

Authors:  J K Yao; R D Reddy; D P van Kammen
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  Tardive dyskinesia.

Authors:  Pratibha G Aia; Gonzalo J Revuelta; Leslie J Cloud; Stewart A Factor
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

8.  Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice.

Authors:  M Lazzarini; C Salum; E A Del Bel
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

9.  Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats.

Authors:  Santhrani Thaakur; G Himabindhu
Journal:  J Neural Transm (Vienna)       Date:  2009-05-15       Impact factor: 3.575

10.  Harpagophytum Procumbens Ethyl Acetate Fraction Reduces Fluphenazine-Induced Vacuous Chewing Movements and Oxidative Stress in Rat Brain.

Authors:  Larissa Finger Schaffer; Catiuscia Molz de Freitas; Ana Paula Chiapinotto Ceretta; Luis Ricardo Peroza; Elizete de Moraes Reis; Bárbara Nunes Krum; Alcindo Busanello; Aline Augusti Boligon; Jéssie Haigert Sudati; Roselei Fachinetto; Caroline Wagner
Journal:  Neurochem Res       Date:  2016-01-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.